Psychedelic-assisted therapy is moving closer to mainstream care. Belinda Morey explains what treatment actually looks like, who may benefit, what the risks are, and why FDA fast-tracking has clinicians and patients paying attention.

John Makohen combines lived experience and counseling expertise to argue that harm reduction is survival, not surrender. Naloxone, fentanyl test strips, medications, and overdose prevention centers keep people alive, reduce harm, and connect them with care.

Jason Shiers launches our Future of Substance Use Treatment Series by asking whether addiction is only pathology—or also an attempted solution. He explores how treatment can honor disease, trauma, psychology, and neuroscience while helping people heal the needs beneath the behavior and move from recovery toward flourishing